A case of calciphylaxis and acute myeloid leukemia: A previously unreported association

Joshua D. Rosenberg, Pamela Boswell, William Miller

Division of Hematology/Oncology, Scripps Green Clinic, La Jolla, USA;.
Division of Hematopathology, Scripps Clinic Medical Group, La Jolla,USA.

DOI: 10.4236/crcm.2013.23061                

Abstract

Calciphylaxis is a condition of induced hypersensitivity in which tissues respond to challenge agents with local calcification. This article reports the first known case of diffuse calciphylaxis associated with acute myeloid leukemia resulting in death from hypoxic respiratory failure and refractory hypotension.

Keywords

Calciphylaxis; Acute Myeloid Leukemia; Respiratory Failure; Hypotension

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Selye, H. (1962) The dermatologic implications of stress and calciphylaxis. Journal of Investigative Dermatology, 39, 259-275. doi:10.1038/jid.1962.111
[2]	Selye, H. (1962) Calciphylaxis. University of Chicago Press, Chicago.
[3]	Selye, H., Gabbiani, G., Strebel, R. (1962) Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology, 71, 554-558. doi:10.1210/endo-71-4-554
[4]	Selye, H., Gentile, G., Pioreschi, P. (1961) Cutaneous molt induced by calciphylaxis in the rat. Science, 134, 1876-1877. doi:10.1126/science.134.3493.1876
[5]	Coates, T., Kirkland, G.S., Dymock, R.B., Murphy, B.F., Brealey, J.K., Mathew, T.S.H., et al. (1998) Cutaneous necrosis from calcific uremic arteriolopathy. The American Journal of Kidney Diseases, 32, 384-391. doi:10.1053/ajkd.1998.v32.pm9740153
[6]	Bleyer, A.J., White, W.L., Choi, M.J. (2000) Calcific small vessel ischemic disease (calciphylaxis) in dialysis patients. International Journal of Artificial Organs, 23, 351-355.
[7]	Torok, L. and Kozepessy, L. (1991) Uraemic gangrene syndrome. Acta Dermto Venereologica, 71, 455-457.
[8]	Dahl, P.R., Winkelmann, R.K. and Connolly, S.M. (1995) The vascular calcification-cutaneous necrosis syndrome. Journal of the American Academy of Dermatology, 33, 53-58. doi:10.1016/0190-9622(95)90010-1
[9]	Weenig, R.H. (2008) Pathogenesis of calciphylaxis: Hans Selye to nuclear factor k-B. Journal of the American Academy of Dermatology, 58, 458-471. doi:10.1016/j.jaad.2007.12.006
[10]	Weenig, R.H., Sewell, L.D., Davis, M.D.P., McCarthy, J.T. and Pittelkow, M.R. (2007) Calciphylaxis: Natural history, risk factor analysis, and outcome. Journal of the American Academy of Dermatology, 56, 569-579. doi:10.1016/j.jaad.2006.08.065
[11]	Nigwekar, S.U., Wolf, M., Sterns, R.H. and Hix, J.K. (2008) Calciphylaxis from nonuremic causes: A systematic review. Clinical Journal of the American Society of Nephrology, 3, 1139-1143. doi:10.2215/CJN.00530108
[12]	Mastruserio, D.N., Nguyen, E.Q., Nielsen, T., Hessel, A. and Pellegrini, A.E. (1999) Calciphylaxis associated with metastatic breast carcinoma. Journal of the American Academy of Dermatology, 41, 295-298. doi:10.1016/S0190-9622(99)70368-3
[13]	Raper, R.F., Ibels, L.S. (1985) Osteosclerotic myeloma complicated by diffuse arteritis, vascular calcification and extensive cutaneous necrosis. Nephron, 39, 389-392. doi:10.1159/000183411
[14]	Sibai, H., Ishak, R.S., Halawi, R., et al. (2012) Non-uremic calcific arteriolopathy (calciphylaxis) in relapsed/ refractory Hogkin’s lymphoma: A previously unreported association. Journal of Clinical Oncology, 30, e88-e90. doi:10.1200/JCO.2011.39.4551
[15]	Goff, H.W. and Grimwood, R.E. (2005) A case of calciphylaxis and chronic myelomonocytic leukemia. Cutis, 75, 325-328.
[16]	Riegert-Johnson, D.L., Kaur, J.S. and Pfeifer, E.A. (2001) Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Mayo Clinic Proceedings, 76, 749-752. doi:10.4065/76.7.749
[17]	Kutlu, N.O., Aydin, N.E., Aslan, M., et al. (2003) Malignant melanoma of the soft parts showing calciphylaxis. Pediatric Hematology Oncology, 20, 141-146. doi:10.1080/0880010390158621
[18]	Ahmed, S., O’Neill, K.D., Hood, A.F., Evan, A.P. and Moe, S.M. (2001) Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. The American Journal of Kidney Diseases, 37, 1267-1276. doi:10.1053/ajkd.2001.24533
[19]	Kalajian, A.H., Malhotra, P.S., Callen, J.P., et al. (2009) Calciphylaxis with normal renal and parathyroid function: Not as rare as previously believed. Archives of Dermatology, 145, 451-458. doi:10.1001/archdermatol.2008.602
[20]	LaCelle, P.L. (1986) Alterations by leukocytes of erythrocyte flow in microchannels. Blood Cells, 12, 179-189.
[21]	Robinson, M.R., Augustine, J.J. and Korman, N.J. (2007) Cinacalcet for the treatment of calciphylaxis. Archives of Dermatology, 143, 152-154. doi:10.1001/archderm.143.2.152
[22]	Cicone, J.S., Petronis, J.B., Embert, C.D. and Spector, D.A. (2004) Successful treatment of calciphylaxis with intravenous sodium thiosulfate. The American Journal of Kidney Diseases, 43, 1104-1108. doi:10.1053/j.ajkd.2004.03.018
[23]	Shiraishi, N., Kitamura, K., Miyoshi, T., et al. (2006) Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. The American Journal of Kidney Diseases, 48, 151-154. doi:10.1053/j.ajkd.2006.04.062
[24]	Monney, P., Nguyen, Q.V., Perroud, H. and Descombes, E. (2004) Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrology Dialysis Transplantation, 19, 2130-2132. doi:10.1093/ndt/gfh305
[25]	Podymow, T., Wherrett, C. and Burns, K.D. (2001) Hyperbaric oxygen in the treatment of calciphylaxis: A case series. Nephrology Dialysis Transplantation, 16, 2176-2180. doi:10.1093/ndt/16.11.2176
[26]	Block, G.A. (2000) Prevalence and clinical consequences of elevated Ca × P product in hemodialysis patients. Clinical Nephrology, 54, 318-324.